Kai Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kai Zhao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Lin Xiao
Department of Orthopaedics, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
3 shared publications Jiang-Jun Zhou
Hospital 908, Joint Logistics Support Force, Nanchang, Jiangxi, China
3 shared publicationsMin Zhao
Department of Spine Surgery, Yingtan People's Hospital, Yingtan, Jiangxi, China
2 shared publications- Wuyang Liu
Department of Orthopaedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China
2 shared publications Yu Xing
Department of Orthopaedics, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
2 shared publicationsYuan-Zhang Xiao
Department of Orthopaedics, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
2 shared publications
Latest Publications
- 12 October 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1711
Non-coding RNAs regulating autophagy in Osteoporosis: mechanistic insights and therapeutic potential
- 12 October 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1711
Non-coding RNAs regulating autophagy in Osteoporosis: mechanistic insights and therapeutic potential
- Open Access
- 20 November 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1742278
Correction: The role of oxidative stress in spinal cord ischemia reperfusion injury: mechanisms and therapeutic implications
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* )In the published article, there was a mistake in the designation of co-first authors. The author List was erroneously given as [Yu Xing 1,2 , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* † and Chun-Lin Xiao 1,2* ]. The dagger symbol " †" should be placed next to Yu Xing's name, rather than Kai Zhao's. The correct author list is [Yu Xing 1,2 † , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* ].here, please contact the journal's editorial office.
- 20 November 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1742278
Open AccessCorrection: The role of oxidative stress in spinal cord ischemia reperfusion injury: mechanisms and therapeutic implications
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* )In the published article, there was a mistake in the designation of co-first authors. The author List was erroneously given as [Yu Xing 1,2 , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* † and Chun-Lin Xiao 1,2* ]. The dagger symbol " †" should be placed next to Yu Xing's name, rather than Kai Zhao's. The correct author list is [Yu Xing 1,2 † , Yuan-Zhang Xiao 1,2 † , Min Zhao 3 , Jiang-Jun Zhou 4 , Kai Zhao 1,2* and Chun-Lin Xiao 1,2* ].here, please contact the journal's editorial office.
- Top Cited PapersOpen Access
- 24 June 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1590493
The role of oxidative stress in spinal cord ischemia reperfusion injury: mechanisms and therapeutic implications
Spinal cord ischemia/reperfusion injury (SCIRI) is a serious disease that leads to the loss of sensory and motor functions and is a common complication after spinal cord injury, spinal cord degeneration or thoracic and abdominal aortic surgery. At present, the spinal cord is mainly protected from ischemic injury through treatment strategies such as hypothermia, surgery and drug assistance, but these intervention measures cannot effectively improve these conditions. SCIRI is a complex process that leads to cell damage and death. Among them, oxidative stress is an important pathological event of ischemia/reperfusion injury. Oxidative stress can initiate multiple inflammatory and apoptotic pathways, triggering a series of destructive events such as inflammatory responses and cell death, further deteriorating the microenvironment at the injured site, and leading to neurological dysfunction. Based on the important role of oxidative stress in SCIRI, we believe that targeted inhibition of oxidative stress responses can effectively reduce secondary injuries caused by trauma, which has a certain positive effect on the rehabilitation and prognosis of patients with SCIRI. This review systematically expounds the spatiotemporal dynamic characteristics of oxidative stress during the SCIRI process and its molecular regulatory network, with a focus on analyzing the multivariate generation mechanism of ROS. To deeply explore the regulatory effects of ROS on pathological processes such as neuronal death, inflammatory response and blood-spinal barrier disruption under SCIRI conditions, as well as its interaction patterns with signaling pathways. In order to form a systematic treatment for SCIRI caused by oxidative stress and promote the recovery of neurological function after injury. This review is helpful for us to understand the effect of oxidative stress on SCIRI and provides a theoretical basis for the treatment of SCIRI based on oxidative stress.
- 24 June 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 19, 1590493
Top Cited PapersOpen AccessThe role of oxidative stress in spinal cord ischemia reperfusion injury: mechanisms and therapeutic implications
Spinal cord ischemia/reperfusion injury (SCIRI) is a serious disease that leads to the loss of sensory and motor functions and is a common complication after spinal cord injury, spinal cord degeneration or thoracic and abdominal aortic surgery. At present, the spinal cord is mainly protected from ischemic injury through treatment strategies such as hypothermia, surgery and drug assistance, but these intervention measures cannot effectively improve these conditions. SCIRI is a complex process that leads to cell damage and death. Among them, oxidative stress is an important pathological event of ischemia/reperfusion injury. Oxidative stress can initiate multiple inflammatory and apoptotic pathways, triggering a series of destructive events such as inflammatory responses and cell death, further deteriorating the microenvironment at the injured site, and leading to neurological dysfunction. Based on the important role of oxidative stress in SCIRI, we believe that targeted inhibition of oxidative stress responses can effectively reduce secondary injuries caused by trauma, which has a certain positive effect on the rehabilitation and prognosis of patients with SCIRI. This review systematically expounds the spatiotemporal dynamic characteristics of oxidative stress during the SCIRI process and its molecular regulatory network, with a focus on analyzing the multivariate generation mechanism of ROS. To deeply explore the regulatory effects of ROS on pathological processes such as neuronal death, inflammatory response and blood-spinal barrier disruption under SCIRI conditions, as well as its interaction patterns with signaling pathways. In order to form a systematic treatment for SCIRI caused by oxidative stress and promote the recovery of neurological function after injury. This review is helpful for us to understand the effect of oxidative stress on SCIRI and provides a theoretical basis for the treatment of SCIRI based on oxidative stress.
- Top Cited Papers
- 2 August 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (2) , 2230-2249
Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury
Spinal cord injury (SCI) is a serious, disabling injury to the central nervous system that can lead to motor, sensory, and autonomic dysfunction below the injury plane. SCI can be divided into primary injury and secondary injury according to its pathophysiological process. Primary injury is irreversible in most cases, while secondary injury is a dynamic regulatory process. Secondary injury involves a series of pathological events, such as ischemia, oxidative stress, inflammatory events, apoptotic pathways, and motor dysfunction. Among them, oxidative stress is an important pathological event of secondary injury. Oxidative stress causes a series of destructive events such as lipid peroxidation, DNA damage, inflammation, and cell death, which further worsens the microenvironment of the injured site and leads to neurological dysfunction. The nuclear factor erythrocyte 2–associated factor 2 (Nrf2) is considered to be a key pathway of antioxidative stress and is closely related to the pathological process of SCI. Activation of this pathway can effectively inhibit the oxidative stress process and promote the recovery of nerve function after SCI. Therefore, the Nrf2 pathway may be a potential therapeutic target for SCI. This review deeply analyzed the generation of oxidative stress in SCI, the role and mechanism of Nrf2 as the main regulator of antioxidant stress in SCI, and the influence of cross-talk between Nrf2 and related pathways that may be involved in the pathological regulation of SCI on oxidative stress, and summarized the drugs and other treatment methods based on Nrf2 pathway regulation. The objective of this paper is to provide evidence for the role of Nrf2 activation in SCI and to highlight the important role of Nrf2 in alleviating SCI by elucidating the mechanism, so as to provide a theoretical basis for targeting Nrf2 pathway as a therapy for SCI.
- 2 August 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (2) , 2230-2249
Top Cited PapersNrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury
Spinal cord injury (SCI) is a serious, disabling injury to the central nervous system that can lead to motor, sensory, and autonomic dysfunction below the injury plane. SCI can be divided into primary injury and secondary injury according to its pathophysiological process. Primary injury is irreversible in most cases, while secondary injury is a dynamic regulatory process. Secondary injury involves a series of pathological events, such as ischemia, oxidative stress, inflammatory events, apoptotic pathways, and motor dysfunction. Among them, oxidative stress is an important pathological event of secondary injury. Oxidative stress causes a series of destructive events such as lipid peroxidation, DNA damage, inflammation, and cell death, which further worsens the microenvironment of the injured site and leads to neurological dysfunction. The nuclear factor erythrocyte 2–associated factor 2 (Nrf2) is considered to be a key pathway of antioxidative stress and is closely related to the pathological process of SCI. Activation of this pathway can effectively inhibit the oxidative stress process and promote the recovery of nerve function after SCI. Therefore, the Nrf2 pathway may be a potential therapeutic target for SCI. This review deeply analyzed the generation of oxidative stress in SCI, the role and mechanism of Nrf2 as the main regulator of antioxidant stress in SCI, and the influence of cross-talk between Nrf2 and related pathways that may be involved in the pathological regulation of SCI on oxidative stress, and summarized the drugs and other treatment methods based on Nrf2 pathway regulation. The objective of this paper is to provide evidence for the role of Nrf2 activation in SCI and to highlight the important role of Nrf2 in alleviating SCI by elucidating the mechanism, so as to provide a theoretical basis for targeting Nrf2 pathway as a therapy for SCI.
- Top Cited PapersOpen Access
- 19 October 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113881
The role of PI3K/Akt signalling pathway in spinal cord injury
- 19 October 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113881
Top Cited PapersOpen AccessThe role of PI3K/Akt signalling pathway in spinal cord injury
- Open Access
- 1 July 2022
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 11 (7) , 413-425
Accumulation of advanced oxidation protein products contributes to age-related impairment of gap junction intercellular communication in osteocytes of male mice
Aims: Gap junction intercellular communication (GJIC) in osteocytes is impaired by oxidative stress, which is associated with age-related bone loss. Ageing is accompanied by the accumulation of advanced oxidation protein products (AOPPs). However, it is still unknown whether AOPP accumulation is involved in the impairment of osteocytes’ GJIC. This study aims to investigate the effect of AOPP accumulation on osteocytes’ GJIC in aged male mice and its mechanism.Methods: Changes in AOPP levels, expression of connexin43 (Cx43), osteocyte network, and bone mass were detected in 18-month-old and three-month-old male mice. Cx43 expression, GJIC function, mitochondria membrane potential, reactive oxygen species (ROS) levels, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation were detected in murine osteocyte-like cells (MLOY4 cells) treated with AOPPs. The Cx43 expression, osteocyte network, bone mass, and mechanical properties were detected in three-month-old mice treated with AOPPs for 12 weeks.Results: The AOPP levels were increased in aged mice and correlated with degeneration of osteocyte network, loss of bone mass, and decreased Cx43 expression. AOPP intervention induced NADPH oxidase activation and mitochondrial dysfunction, triggered ROS generation, reduced Cx43 expression, and ultimately impaired osteocytes’ GJIC, which were ameliorated by NADPH oxidase inhibitor apocynin, mitochondria-targeted superoxide dismutase mimetic (mito-TEMPO), and ROS scavenger N-acetyl cysteine. Chronic AOPP loading accelerated the degradation of osteocyte networks and decreased Cx43 expression, resulting in deterioration of bone mass and mechanical properties in vivo.Conclusion: Our study suggests that AOPP accumulation contributes to age-related impairment of GJIC in osteocytes of male mice, which may be part of the pathogenic mechanism responsible for bone loss during ageing. Cite this article: Bone Joint Res 2022;11(7):413–425.
- 1 July 2022
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 11 (7) , 413-425
Open AccessAccumulation of advanced oxidation protein products contributes to age-related impairment of gap junction intercellular communication in osteocytes of male mice
Aims: Gap junction intercellular communication (GJIC) in osteocytes is impaired by oxidative stress, which is associated with age-related bone loss. Ageing is accompanied by the accumulation of advanced oxidation protein products (AOPPs). However, it is still unknown whether AOPP accumulation is involved in the impairment of osteocytes’ GJIC. This study aims to investigate the effect of AOPP accumulation on osteocytes’ GJIC in aged male mice and its mechanism.Methods: Changes in AOPP levels, expression of connexin43 (Cx43), osteocyte network, and bone mass were detected in 18-month-old and three-month-old male mice. Cx43 expression, GJIC function, mitochondria membrane potential, reactive oxygen species (ROS) levels, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation were detected in murine osteocyte-like cells (MLOY4 cells) treated with AOPPs. The Cx43 expression, osteocyte network, bone mass, and mechanical properties were detected in three-month-old mice treated with AOPPs for 12 weeks.Results: The AOPP levels were increased in aged mice and correlated with degeneration of osteocyte network, loss of bone mass, and decreased Cx43 expression. AOPP intervention induced NADPH oxidase activation and mitochondrial dysfunction, triggered ROS generation, reduced Cx43 expression, and ultimately impaired osteocytes’ GJIC, which were ameliorated by NADPH oxidase inhibitor apocynin, mitochondria-targeted superoxide dismutase mimetic (mito-TEMPO), and ROS scavenger N-acetyl cysteine. Chronic AOPP loading accelerated the degradation of osteocyte networks and decreased Cx43 expression, resulting in deterioration of bone mass and mechanical properties in vivo.Conclusion: Our study suggests that AOPP accumulation contributes to age-related impairment of GJIC in osteocytes of male mice, which may be part of the pathogenic mechanism responsible for bone loss during ageing. Cite this article: Bone Joint Res 2022;11(7):413–425.